10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Pandemic preparedness is a critical aspect of global health security, involving the development of strategies to mitigate and respond to potential outbreaks before they escalate into widespread public health crises. Effective Pandemic Preparedness: Global Strategies for Mitigation and Response include early detection systems, rapid mobilization of resources, and coordinated international cooperation to contain the spread of infectious diseases. Public health frameworks, such as the World Health Organization's International Health Regulations, guide countries in preparing for and responding to pandemics. Key elements of these strategies involve strengthening healthcare systems, improving surveillance, and ensuring equitable access to vaccines and treatments. By implementing robust pandemic preparedness plans, the global community can better protect populations and minimize the societal and economic impacts of future pandemics.
By signing up, you agree to join our mailing list to receive information and updates.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : The impact of expanded adolescent vaccination against Omicron waves depends on the epidemic status: A mathematical modelling study
Anna Fairweather, University of Oxford, United Kingdom
Title : Comprehensive HIV care through integrated STI and primary care services at the LGBTQ+ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Meeting the needs of adults aged 50+ with HIV through the new opening of a primary care clinic at the LGBTQ Center of Southern Nevada
Darya V Fridman, The Southern Nevada LGBTQ+ Center, United States
Title : Camostat-polysaccharide dual-action nasal spray for mucosal barrier-driven prevention of viral infections
Yujeong Na, Daewoong Pharmaceutical Co., Ltd, Korea, Democratic People's Republic of